Cancer Institute of New Jersey (CINJ), Breast Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Breast Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Triple Negative Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Paclitaxel Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Mutation Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Nancy Chan

Nancy Chan

Person

No photo of Kim Hirshfield

Kim Hirshfield

Person

19932019
No photo of Shicha Kumar

Shicha Kumar

Person

20102017

Projects 2012 2018

Modifying The Risk For Developing Triple Negative Breast Cancer (Tnbc)

Omene, C.

National Institutes of Health (NIH)

9/15/12 → 5/31/18

Project: Research project

Triple Negative Breast Neoplasms
Breast Neoplasms
Neoplasms
Histone Deacetylase Inhibitors
Estrogen Receptors

Research Output 1992 2019

5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost

Gupta, A., Khan, A., Yegya-Raman, N., Sayan, M., Ahlawat, S., Ohri, N., Goyal, S., Moore, D., Eladoumikdachi, F., Toppmeyer, D. & Haffty, B., Oct 1 2019, In : International Journal of Radiation Oncology Biology Physics. 105, 2, p. 267-274 8 p.

Research output: Contribution to journal › Article

acceleration (physics)
breast
radiation therapy
Breast
Radiotherapy

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Sayan, M., Abou Yehia, Z., Gupta, A., Toppmeyer, D., Ohri, N. & Haffty, B. G., Oct 1 2019, In : Frontiers in Oncology. 9, 970.

Research output: Contribution to journal › Article

Open Access
Radiotherapy
Breast Neoplasms
Stroke Volume
Cardiotoxicity
Trastuzumab
3 Citations (Scopus)

A Pharmacogenetic Prediction Model of Progression-Free Survival in Breast Cancer using Genome-Wide Genotyping Data from CALGB 40502 (Alliance)

Rashkin, S. R., Chua, K. C., Ho, C., Mulkey, F., Jiang, C., Mushiroda, T., Kubo, M., Friedman, P. N., Rugo, H. S., McLeod, H. L., Ratain, M. J., Castillos, F., Naughton, M., Overmoyer, B., Toppmeyer, D., Witte, J. S., Owzar, K. & Kroetz, D. L., Mar 1 2019, In : Clinical pharmacology and therapeutics. 105, 3, p. 738-745 8 p.

Research output: Contribution to journal › Article

Pharmacogenetics
Disease-Free Survival
Area Under Curve
Genome
Breast Neoplasms